
Dow Futures Rise Amid Robust Earnings, Netflix Pops 7.4%
By Oliver Gray Investing.com - Dow futures were trading higher during Tuesday’s evening deals, following a strong session for major indices as robust earnings results drove investor...
By Oliver Gray Investing.com - Dow futures were trading higher during Tuesday’s evening deals, following a strong session for major indices as robust earnings results drove investor...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Industrials, Technology and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Pre-Open Stock Movers:Apellis Pharmaceuticals, Inc. (Nasdaq: NASDAQ:APLS) 23% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review...
By Senad Karaahmetovic Shares of Johnson & Johnson (NYSE:JNJ) are up more than 1% in premarket trading after the company’s coronavirus vaccine sales smashed analyst estimates. The...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, July 19th. Please refresh for updates. IBM (NYSE:IBM) stock fell 5.8% after the tech giant lowered its...
By Peter Nurse Investing.com -- U.S. stocks are seen opening higher Tuesday, rebounding after the previous session’s losses as a busy week of corporate earnings continues. At 07:00 AM ET...
Johnson & Johnson (NYSE:JNJ) reported Q2 EPS of $2.59, $0.04 better than the analyst estimate of $2.55. Revenue for the quarter came in at $24 billion versus the consensus estimate of $23.8...
Investing.com - J&J reported on Tuesday second quarter {{erl-8177||earnings that beat analysts' forecasts and revenue that topped expectations. J&J announced earnings per share of...
By Oliver Gray Investing.com - U.S. stock futures were trading flat during Monday’s evening deals, following a negative close among major benchmark indices as numerous positive...
By Liz Moyer Investing.com -- Stocks turned negative on Monday as earnings kicked off with big banks, and later, big tech. What spooked investors was a report that Apple (NASDAQ:AAPL) was...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Healthcare, Utilities and Telecoms sectors propelled shares lower. At the close in NYSE, the Dow Jones...
By Oliver Gray Investing.com - U.S. stock futures were mostly higher during Sunday’s overnight deals, with major benchmark averages coming off a losing week despite a strong relief rally on...
By Daniel Shvartsman Investing.com - Corporate earnings step to the center stage this week. Last week’s bank earnings saw mixed results, and the CPI report overshoot and subsequent Federal...
Here are previews of five companies set to report quarterly results late Monday or early Tuesday, including IBM and Johnson & Johnson.
Johnson & Johnson does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE and Pfizer Inc. , and Novavax Inc. are already working on new...
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Oil & Gas, Basic Materials and Industrials sectors propelled shares lower. At the close in NYSE, the Dow...
The FDA's Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. At a Tuesday meeting with the FDA's public advisory committee, the...
By Davit Kirakosyan Novavax, Inc. (NASDAQ:NVAX) announced late Tuesday that the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC)...
Johnson & Johnson said Monday it planned to terminate its COVID-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of...
Johnson & Johnson said it planned to terminate the deal with contract manufacturer Emergent BioSolutions, as both companies accused each other of breaching the agreement.
Johnson & Johnson (NYSE: JNJ) and AbbVie Inc (NYSE: ABBV) announced primary results from the Phase 3 SHINE study of Imbruvica (ibrutinib) plus bendamustine-rituximab (BR) and rituximab...
Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines. Emergent said J&J...
(Reuters) – Contract manufacturer Emergent BioSolutions Inc said on Monday U.S. drugmaker Johnson & Johnson had breached an agreement by failing to buy the minimum quantity of COVID-19...
By Michael Erman (Reuters) – Johnson & Johnson and AbbVie’s big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Consumer Services, Technology and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Oil & Gas and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Oil & Gas and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, May 11th. Please refresh for updates. Coinbase (NASDAQ:COIN) stock slumped 15% after the cryptocurrency...
By Liz Moyer Investing.com -- U.S. stocks sank further on Friday, extending into a second day of losses despite a better-than-expected report on job creation in April. At 10:24 AM ET, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Oil & Gas, Technology and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow Jones...
J&J (NYSE:JNJ) Snack Foods (JJSF) reported Q2 EPS of $0.17, $0.48 worse than the analyst estimate of $0.65. Revenue for the quarter came in at $281.5 million versus the consensus estimate of...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Consumer Goods, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Telecoms, Basic Materials and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow...
By Yasin Ebrahim Investing.com – The Dow racked up gains Tuesday, as dip-buyers returned to big tech stocks, shrugging off an ongoing melt-up in rates as the quarterly earnings season heats...
By Yasin Ebrahim Investing.com – The S&P 500 racked up gains Tuesday, as dip-buyers returned to big tech stocks, shrugging off an ongoing melt-up in rates ahead of the quarterly results from...
By Sam Boughedda Investing.com -- U.S. stocks are trading higher Tuesday, with the Nasdaq the biggest gainer at +1.88%. Here are the midday movers on Tuesday, April 19th. Checkmate...
By Liz Moyer Investing.com -- Stocks rose in early trading on Tuesday, undeterred by rising bond yields as corporate earnings continued to roll in. At 9:55 AM ET, the Dow Jones Industrial...
Shares of Johnson & Johnson (NYSE:JNJ) are down in premarket trading Tuesday after the company reported {{erl-8177||Q4 results. J&J reported Q4 adjusted EPS of $2.67, topping the consensus...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.